Clinical research directions in pediatric cardiology

Steven E Lipshultz1, James D Wilkinson, Sarah E Messiah

  • 1Department of Pediatrics, Division of Pediatric Clinical Research, University of Miami, Leonard M. Miller School of Medicine, Miami, Florida 33101, USA. slipshultz@med.miami.edu

Insights

A comprehensive research agenda is proposed to address underfunded pediatric cardiology. This plan aims to coordinate research, attract funding, and drive breakthroughs in child cardiovascular health over a lifetime.

Area of Science:

  • Pediatric Cardiology
  • Life-Course Cardiovascular Health
  • Child Cardiovascular Disease

Background:

  • Clinical research in pediatric cardiology is under-appreciated and under-funded.
  • Pediatric cardiovascular health has significant implications for lifelong health.
  • Renewed interest in federal funding necessitates a strategic research agenda.

Purpose of the Study:

  • To propose a comprehensive pediatric cardiology research agenda.
  • To attract public funds for research into child cardiovascular health and disease.
  • To outline key research topics and questions for advancing the field.

Main Methods:

  • Development of a comprehensive research agenda with 22 topics and research questions.
  • Detailed exploration of five key areas: life-course studies, epigenetic factors, cardiometabolic disease risk, clinical trials, physical activity, and evidence-based interventions.
  • Review of recent pediatric cardiology clinical trials and observational studies.

Main Results:

  • A proposed pediatric cardiology research agenda with 22 topics and associated research questions.
  • Detailed examination of life-course studies, epigenetic factors, cardiometabolic disease risk, clinical trials, physical activity, and interventions.
  • Identification of critical research needs in pediatric cardiovascular health.

Conclusions:

  • Adopting a comprehensive research agenda can improve coordination and funding for pediatric cardiology research.
  • Targeted research efforts can lead to breakthroughs in genetics, biomarkers, and cardioprotective strategies.
  • The agenda aims to enhance the financial and scientific efficiency of pediatric cardiology research for improved long-term outcomes.
Abstract

Related Concept Videos

Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...